The increasing prevalence of chronic conditions like cardiovascular disease is driving the demand for transmucosal drugs. Key factors contributing to the transmucosal drugs market's growth from ...

Penmenvy, which protects against five common types of disease-causing bacteria, is cleared for use in people aged 10 through ...

Multiple system atrophy (MSA) is a rare neurological disorder that leads to the progressive deterioration of nerve cells in ...

Amity University Rajasthan successfully hosted E-SUMMIT 2025, a three-day mega event dedicated to fostering innovation, entrepreneurship, and technology, from February 11 to 13, 2025. The summit ...

It’s critical to understand what a digitally savvy HCP is in 2025 and what’s impeding pharma's communications with this ...

The global Microcarriers market, valued at US$2.03 billion in 2023, is forecasted to grow at a robust CAGR of 8.0%, reaching US$2.08 billion ...

SMART Pharmaceutical Consulting is a boutique pharmaceutical and biotechnology consulting firm that provides progressive ...

Tokyo, Japan and Cambridge, UK, 14 February 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) provides an update on operational activities and reports its consolidated results for the ...

Michigan Medicine and Cleveland Clinic researchers have found that patients with irritable bowel syndrome were more likely to ...

Swiss aviation pioneer Bertrand Piccard is developing a plane powered by liquid hydrogen after a much-hyped flight in 2015 ...